Chad Therapeutics Executive to Retire at End of Month
- Share via
Chad Therapeutics has announced that Senior Vice President Frank Fleming will retire March 31.
The Chatsworth company said Fleming’s retirement had been planned since last year. No replacement has been named.
Fleming will become a consultant to the company, primarily in marketing, sales, and government and industry affairs.
Chad develops, manufactures and distributes oxygen-conserving devices and oxygen-delivery systems for home health-care patients who require supplemental oxygen.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
